Therapeutic potential of neuropeptide Y (NPY) receptor ligands
SP Brothers, C Wahlestedt - EMBO molecular medicine, 2010 - embopress.org
Neuropeptide Y (NPY) is widely distributed in the human body and contributes to a vast
number of physiological processes. Since its discovery, NPY has been implicated in …
number of physiological processes. Since its discovery, NPY has been implicated in …
[HTML][HTML] Tumor progression: the neuronal input
M Arese, F Bussolino, M Pergolizzi… - Annals of …, 2018 - ncbi.nlm.nih.gov
One of the challenges of cancer is its heterogeneity and rapid capacity to adapt.
Notwithstanding significant progress in the last decades in genomics and precision …
Notwithstanding significant progress in the last decades in genomics and precision …
[HTML][HTML] Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets
PB Madhamshettiwar, SR Maetschke, MJ Davis… - Genome medicine, 2012 - Springer
Background Altered networks of gene regulation underlie many complex conditions,
including cancer. Inferring gene regulatory networks from high-throughput microarray …
including cancer. Inferring gene regulatory networks from high-throughput microarray …
[HTML][HTML] Role of the nervous system in cancer metastasis
S Li, Y Sun, D Gao - Oncology letters, 2013 - spandidos-publications.com
The notion that tumors lack innervation was proposed several years ago. However, nerve
fibers are irregulatedly found in some tumor tissues. Their terminals interaction with cancer …
fibers are irregulatedly found in some tumor tissues. Their terminals interaction with cancer …
Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development
C Walther, K Mörl… - Journal of Peptide …, 2011 - Wiley Online Library
Abstract NPY, PYY and PP constitute the so‐called NPY hormone family, which exert its
biological functions in humans through YRs (Y1, Y2, Y4 and Y5). Systematic modulation of …
biological functions in humans through YRs (Y1, Y2, Y4 and Y5). Systematic modulation of …
Neuropeptides in Cancer: Friend and Foe?
Neuropeptides are small regulatory molecules found throughout the body, most notably in
the nervous, cardiovascular, and gastrointestinal systems. They serve as neurotransmitters …
the nervous, cardiovascular, and gastrointestinal systems. They serve as neurotransmitters …
DNA methylation profiles and biomarkers of oral squamous cell carcinoma
YF Li, YH Hsiao, YH Lai, YC Chen, YJ Chen, JL Chou… - Epigenetics, 2015 - Taylor & Francis
Oral squamous cell carcinoma (OSCC) constitutes> 90% of oral cancers and is the sixth
most common malignancy among males worldwide and the fourth leading cause of death …
most common malignancy among males worldwide and the fourth leading cause of death …
[HTML][HTML] The role of neuropeptide-stimulated cAMP-EPACs signalling in cancer cells
Neuropeptides are autocrine and paracrine signalling factors and mainly bind to G protein-
coupled receptors (GPCRs) to trigger intracellular secondary messenger release including …
coupled receptors (GPCRs) to trigger intracellular secondary messenger release including …
Nervous system and gastric cancer
K Wang, X Zhao, J Liu, R Zhang, J Li - Biochimica et Biophysica Acta (BBA) …, 2020 - Elsevier
The nervous system has been recently shown to exert impact on gastric cancer directly and
indirectly. Gastric cancer cells invade nerve fibers to induce outgrowth and branching of …
indirectly. Gastric cancer cells invade nerve fibers to induce outgrowth and branching of …
Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line
PJ Medeiros, BK Al‐Khazraji… - … journal of cancer, 2012 - Wiley Online Library
Stress has long been thought of to be associated with increased risk of cancer. Chronic
stress is associated with elevated levels of sympathetic neurotransmitter (norepinephrine …
stress is associated with elevated levels of sympathetic neurotransmitter (norepinephrine …